Real-world outcomes and adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer Meeting Abstract
| Authors: | Zammarrelli, W.; Ma, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Aghajanian, C.; Green, A.; Rubinstein, M.; Makker, V. |
| Abstract Title: | Real-world outcomes and adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer |
| Meeting Title: | Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer (54th Annual Meeting) |
| Journal Title: | Gynecologic Oncology |
| Volume: | 176 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Mar 25-28 |
| Meeting Location: | Tampa, FL |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S79 |
| End Page: | S80 |
| Language: | English |
| ACCESSION: | WOS:001079556100115 |
| DOI: | 10.1016/j.ygyno.2023.06.025 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1103 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
